Risk myocardial infarction death treatment low dose aspirin intravenous heparin men unstable coronary artery disease RISC Group men unstable coronary artery disease unstable angina non-Q-wave myocardial infarction MI double-blind placebo-controlled treatment oral aspirin mg/day days intermittent intravenous heparin risk MI death aspirin days risk ratio confidence intervals month months Aspirin event rate non-Q-wave MI unstable angina electrocardiographic abnormalities concurrent drug therapy Heparin significant influence event rate group aspirin heparin number events initial days Treatment side-effects high patient compliance 